Four potential side-effects of cholesterol-lowering drugs statins
In the early Noughties, "cholesterol" became a bit of a buzzword, with campaigns and advertisements telling us we should care about it – and seek to maintain healthy levels.
And although its prominence in conversation has died down somewhat in recent years, its importance is no less real, with 59% of people in the UK experiencing raised cholesterol in 2021. High levels of cholesterol was most evident in those aged 45 and 64 (72%) and among adults aged 16 to 33, men (53%) were more likely than women (46%) to have raised levels.
Now, a new study has also linked reduced levels of bad cholesterol with curbing the risk of dementia, finding that people with low-density lipoprotein (LDL-C) in their blood are 26% less likely to develop dementia and Alzheimer's disease.
It also looked at the use of statins – cholesterol-lowering medications – and found them to provide an "additional protective effect" against the condition.
Here, we take a look at what statins are, how they work – and the potential side-effects and benefits of the drug.
A group of medicines that help lower the level of LDL cholesterol – "bad cholesterol" – in the blood, statins are designed to reduce the production of it inside the liver.
The drugs are normally prescribed to those with potentially dangerous levels of LDL-C, which, in turn, can lead to the hardening and narrowing of the arteries and result in cardiovascular disease or atherosclerosis.
Coming in tablet form, statins are taken once daily, but the dose will depend on your medical needs. This dosage may also change over time, depending on what your GP deems necessary.
Most people have to continue taking statins throughout their life once they have been prescribed them.
Headaches
Dizziness
Nausea
Digestive problems, such as indigestion, diarrhoea or constipation
Muscle pain
Problems with sleep
Low blood platelet count
Feeling tired or physically weak
Muscle damage – This usually only happens when statins are taken in combination with other medication
Loss of sensation or tingling in the nerve endings
Tendon problems
Hair loss
Memory problems
Skins irritation
Loss of sex drive
Erectile dysfunction
Being sick
Liver damage
In addition to the 2025 study published in the Journal of Neurology, Neurosurgery & Psychiatry (outlined above), a 2016 study published by the same journal also linked statins to a lower risk of dementia and Alzheimer's.
Looking at 400,000 Medicare beneficiaries who used the drugs, the research found that men in the group who had taken the medication regularly for two years had a 12% lower risk of developing Alzheimer's.
Various studies have also looked at the impact statins have on cancer risks, but the results have been inconsistent and there's no conclusive answer right now. More research needs to be done to gauge whether statins can, indeed, lower the risk of certain cancers.
The drugs have also been found to reduce inflammation and irritation, and the exacerbation of atherosclerosis, which is a major cause of coronary artery disease (CAD).
Research published by Nature Communications in 2019 discovered a new link between statins and immune systems. It found that by using medications like statins, they could modify cell responses in the lab. Professor Andrew Cope, lead investigator of the study, said: "We think that our findings could explain why people taking statins are better at fighting influenza, and why patients have better outcomes for some types of cancer."
Read more about health conditions:
Seven health conditions you can visit your pharmacy for (Yahoo Life UK, 4-min read)
Seven chronic health conditions you've (probably) never heard of (Yahoo Life UK, 6-min read)
Six crucial things to learn about your health - before it's too late (Yahoo Life UK, 7-min read)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Why Oscar Health, Inc. (OSCR) Soared On Thursday
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other best-performing stocks on Thursday. Oscar Health snapped a five-day losing streak on Thursday, jumping 10.6 percent to close at $15.65 apiece as investors resorted to bargain-hunting while waiting for more concrete developments on the Trump administration's Medicare Advantage review. Earlier this year, lawmakers passed a $5-trillion tax-and-spending package that shaves as much as $900 billion in Medicaid, which servers over 70 million low-income households. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Now, Senate Republicans to broaden savings by looking for supposed inefficiencies in the Medicare program for senior citizens. In the first quarter of the year, Oscar Health, Inc. (NYSE:OSCR) registered a 55-percent increase in attributable net income of $275 million versus the $177 million registered in the same period last year. Revenues rose by 42 percent to $3.046 billion from $2.142 billion year-on-year. Overall, OSCR ranks 5th on our list of best-performing stocks on Thursday. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Time Business News
5 hours ago
- Time Business News
Comprehensive Senior Memory Support Services for Dementia Care
As we age, cognitive decline becomes a genuine concern for many families. Caring for loved ones with dementia or Alzheimer's disease can be overwhelming. Fortunately, senior memory support services are here to provide the necessary support. These services are tailored to meet the unique needs of seniors and ensure they receive the compassionate and dignified care they deserve. Let's explore how these services can provide you with the care you need. Senior memory support services include different programs and resources that help older adults with memory problems. These services range from special memory care homes for people with dementia to help provided in their own homes. They offer full support to meet different needs. More than 50 million people around the world have dementia, and that number is growing. This shows the importance of having strong support systems in place. Memory support can take different forms, depending on the level of care required. Here are some common types of services: These are special living places for seniors with dementia. Staff are available all day and night to help with daily needs. They also offer planned activities that keep residents engaged and active. Caregivers come to the senior's home to help with daily tasks. This support allows the person to remain in a familiar space. It helps them feel more independent while remaining safe. These programs give seniors a chance to take part in group activities during the day. They often include games, music, and light exercise. At the same time, caregivers get a break from full-time care. Respite care gives short-term help when the main caregiver needs time off. It can take place at home or in a care center. During this time, trained staff care for seniors to keep them safe and comfortable. A key part of good memory care for seniors is making it personal. Each person with dementia has a different experience, so their care should match their needs. Personalized memory care for dementia focuses on the person's past, likes, and daily habits. Utilizing familiar activities and surroundings helps seniors feel more comfortable and enhances their well-being. Choosing the right memory care for a loved one requires careful consideration. First, think about how much help they need. Do they need care all the time, or can they still do some things on their own? Then, look at different care options. Visit the places, talk to the staff, and read reviews. Ensure that the setting is safe and supports your loved one in staying active and social. The main goal of memory care is to help seniors with dementia live with dignity and enjoy a better quality of life. It's important to give kind, ongoing care as families face these hard times. Choosing personal care now can help build a strong support system, giving your loved one the best chance to do well. If you are looking for support, check out the programs in your area. Taking action today can help your loved one have a brighter and more fulfilling future. Is this article helpful? Keep reading our blog for more. TIME BUSINESS NEWS
Yahoo
12 hours ago
- Yahoo
IVF parents are spending thousands to predict their babies' chances of having Alzheimer's, cancer and heart disease
Maybe she's born with it, maybe it's … genetic optimization? Prospective parents using in vitro fertilization (IVF) will soon be able to select embryos based on their potential risk for diseases — including illnesses that develop later in life — thanks to a groundbreaking $5,999 service announced this week by a US biotech company. 'Before there's a heartbeat, there's DNA,' Kian Sadeghi, founder and chief executive of Nucleus Genomics, said in a statement. 'One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage.' The popular fertility treatment involves removing eggs from a woman's ovaries and fertilizing them with sperm in a lab. The resulting embryo — which could be frozen or fresh — is placed into the uterus, where it hopefully implants in the uterine wall and sparks a pregnancy. Before implantation, many IVF clinics already screen embryos for genetic abnormalities — such as extra chromosomes or gene mutations — that can lead to failed implantations, miscarriages, birth defects or inherited disorders. But the first-of-its-kind service from Nucleus Genomics takes things a step further. The company just launched Nucleus Embryo, a new software platform that lets potential parents dig deep into the full genetic blueprint of their embryos before choosing which one to implant. The tool lets IVF patients compare the DNA of up to 20 embryos, screening them for more than 900 conditions — including Alzheimer's, Type 2 diabetes, heart disease and several forms of cancer. It doesn't stop there. The program also flags potential mental health conditions like depression and schizophrenia and even ranks cognitive traits like IQ. Parents can also get a look at cosmetic and physical features, from height, baldness and BMI to eye and hair color. The company isn't promising perfection. Instead, the software generates a so-called polygenic risk score that will give parents the probability of how likely it is an embryo might develop certain traits or diseases. Ultimately, it's up to the parents to decide which qualities matter most to them. For those looking to decode the results, genetic counseling sessions are available. 'Lifespan has dramatically increased in the last 150 years,' Sadeghi told the Wall Street Journal. 'DNA testing to predict and reduce chronic disease can make it happen again.' The practice, known as polygenic embryo screening, is already highly controversial in the medical world, according to a report published by Harvard Law School's Petrie-Flom Center. Critics warn that allowing parents to screen embryos for risks like depression or diabetes could deepen stigma and discrimination against people living with those conditions. Meanwhile, disability advocates argue it promotes the harmful idea that disability is something to be fixed, not a natural part of human diversity. And when it comes to choosing embryos for traits like intelligence or athleticism, critics say we're sliding into designer baby territory — a modern form of eugenics that favors the rich, reinforcing social and healthcare inequalities. Still, the public appears open to some aspects of the tech. A 2023 survey found that 77% of Americans support using it to screen embryos for the likelihood of developing certain physical conditions, while 72% back screening for mental health risks. Proponents argue it's no different from vaccination — a preventive tool, not a judgment on those with the condition. But when it comes to non-medical traits, support drops fast: only 36% back screening embryos for behavioral traits and just 30% for physical features like height or eye color.